ArticleSupportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer2025
Differences in cancer-related crowdfunding between transgender or gender diverse and cisgender LGBTQ+ cancer campaigns: a mixed-methods analysis.
Article in Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Update and new advances in fertility preservation and cancer.CA: a cancer journal for cliniciansReview
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
purposeLesbian, Gay, Bisexual, Transgender, Queer, Plus (LGBTQ+) cancer survivors are at risk of financial hardship due to multilevel factors amplified by anti-LGBTQ+ stigma. Transgender and gender diverse (TGD) cancer survivors may experience greater financial hardship than cisgender lesbian, gay, and bisexual (LGB) individuals, but data on LGBTQ+ individuals is often reported in aggregate. We describe differences in crowdfunding experiences between TGD and LGB cancer crowdfunding campaigns to address this gap in TGD cancer-related financial hardship literature.
methodsWe used a mixed methods approach to evaluate LGBTQ+ cancer crowdfunding campaigns from GoFundMe's website, coded as TGD or LGB. Campaign data (amount raised, funding goal, etc.) were compared using summary statistics and independent t-tests. Qualitative content analysis described campaign text. Quantitative and qualitative findings were integrated by theme.
resultsA total of N = 470 LGBTQ+ cancer campaigns were included for this analysis, of which 175 (32.5%) were TGD campaigns and 295 (54.8%) were LGB. TGD campaigns raised 39% less than LGB campaigns ($7782 [$5842-$9723] vs. $12,724 [$10,525-$14,924], p < 0.0001). TGD campaigns had more mentions of perceived stigma in healthcare spaces and fewer mentions of caregiver support.
conclusionsTGD cancer campaigns earned significantly less money than LGB campaigns, suggesting that TGD cancer survivors may face more challenges in using community-based financial support mechanisms to mitigate financial hardship. Structural stigma and transphobia may be impacting the amount of funds raised by TGD cancer survivors through crowdfunding.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.